Objects
Hansen, Maren F., Johansen, Jostein, Sjursen, Wenche, Sylvander, Anna E., Bjørnevoll, Inga, Talseth-Palmer, Bente A., Lavik, Liss A. S., Xavier, Alexandre, Engebretsen, Lars F., Scott, Rodney J., Drabløs, Finn. Wiley-Blackwell; 2017. Use of multigene-panel identifies pathogenic variants in several CRC-predisposing genes in patients previously tested for Lynch Syndrome.
Xavier, Alexandre, Campagna, Maria Pia, Lechner-Scott, Jeannette, Ausimmune Investigator Group,, Maltby, Vicki E., Kilpatrick, Trevor, Taylor, Bruce V., Butzkueven, Helmut, Ponsonby, Anne-Louise, Scott, Rodney J., Jokubaitis, Vilija G., Lea, Rodney A.. Frontiers Research Foundation; 2023. Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosis.
Campagna, Maria Pia, Xavier, Alexandre, Lea, Rodney A., Jokubaitis, Vilija G., Stankovich, Jim, Maltby, Vicki E., Slee, Mark, Yeh, Wei Z., Kilpatrick, Trevor, Scott, Rodney J., Butzkueven, Helmut, Lechner-Scott, Jeannette. BioMed Central (BMC); 2023. Parity is associated with long-term differences in DNA methylation at genes related to neural plasticity in multiple sclerosis.
Maltby, Vicki, Xavier, Alexandre, Slee, Mark, van der Mei, Ingrid A., Taylor, Bruce V., Ponsonby, Anne-Louise, Jagodic, Maja, Lea, Rodney, Lechner-Scott, Jeannette, Ewing, Ewoud, Campagna, Maria-Pia, Sampangi, Sandeep, Scott, Rodney J., Butzkueven, Helmut, Jokubaitis, Vilija, Kular, Lara, Bos, Steffan. Wolters Kluwer; 2023. Evaluation of Cell-Specific Epigenetic Age Acceleration in People With Multiple Sclerosis.
Maltby, Vicki E., Lea, Rodney A., Burnard, Sean, Xavier, Alexandre, Van Cao, Thao, White, Nicole, Kennedy, Daniel, Groen, Kira, Sanders, Katherine A., Seeto, Rebecca, Bray, Samara, Gresle, Melissa, Laverick, Louise, Butzkueven, Helmut, Scott, Rodney J., Lechner-Scott, Jeannette. Nature Publishing Group; 2020. Epigenetic differences at the HTR2A locus in progressive multiple sclerosis patients.
Xavier, Alexandre, Maltby, Vicki E., Jokubaitis, Vilija G., Kilpatrick, Trevor, Alfredsson, Lars, Jagodic, Maja, Ponsonby, Anne-Louise, Taylor, Bruce V., Scott, Rodney J., Lea, Rodney A., Lechner-Scott, Jeannette, Ewing, Ewoud, Campagna, Maria Pia, Burnard, Sean M., Tegner, Jesper N., Slee, Mark, Butzkueven, Helmut, Kockum, Ingrid, Kular, Lara. MDPI AG; 2023. DNA Methylation Signatures of Multiple Sclerosis Occur Independently of Known Genetic Risk and Are Primarily Attributed to B Cells and Monocytes.
Binder, Michele D., Nwoke, Eze C., Morwitch, Ellen, Dwyer, Chris, Li, Vivien, Xavier, Alexandre, Lea, Rodney A., Lechner-Scott, Jeannette, Taylor, Bruce V., Ponsonby, Anne-Louise, Kilpatrick, Trevor J., Ausimmune Investigator Group, Dwyer, Chris. Lippincott Williams & Wilkins; 2024. HLA-DRB1*15:01 and the MERTK Gene Interact to Selectively Influence the Profile of MERTK-Expressing Monocytes in Both Health and MS.
Campagna, Maria Pia, Xavier, Alexandre, Lea, Rodney A., Stankovich, Jim, Maltby, Vicki E., Butzkueven, Helmut, Lechner-Scott, Jeannette, Scott, Rodney J., Jokubaitis, Vilija G.. BioMed Central (BMC); 2022. Whole-blood methylation signatures are associated with and accurately classify multiple sclerosis disease severity.
Kiltschewskij, Dylan J., Reay, William R., Cairns, Murray J., Geaghan, Michael P., Atkins, Joshua R., Xavier, Alexandre, Zhang, Xiajie, Watkeys, Oliver J., Carr, Vaughan J., Scott, Rodney J., Green, Melissa J.. Elsevier; 2024. Alteration of DNA Methylation and Epigenetic Scores Associated with Features of Schizophrenia and Common Variant Genetic Risk.